Institutional Interest in Dyadic Grows as Analysts Maintain Optimism Truist Financial Corp recently acquired a significant stake in Dyadic International, purchasing 250,000 shares valued at $428,000. Analysts continue to endorse the company, with a $6.00 price target indicating confidence in its long-term growth potential, driven by its innovative biotech solutions.56